Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Response-guided Triple-therapy Using Boceprevir in Combination With PEGIFN/RBV in HIV/HCV-coinfected Patients

NCT01925183 is registered in ClinicalTrials.gov with Markus Peck-Radosavljevic as lead sponsor.

NCT NCT01925183
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925183 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Response-guided Triple-therapy Using Boceprevir in Combination With PEGIFN/RBV in HIV/HCV-coinfected Patients
Lead sponsor
Markus Peck-Radosavljevic
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2013
Completion date
June 30, 2015
Enrollment
6 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis c, chronic, hiv